test

Anthony Cordone

@Armistice Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$6.253BTotal holdings256
Assets growth rate-21.32%Assets growth rate (2-Q avg)-7.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Armistice Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 256 positions.

Assets under management

The assets under management (AUM) of Armistice Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.253B in assets, with a quarterly growth rate of -21.32% and a 2-quarter average growth rate of -7.96%. The portfolio is managed by Anthony Cordone, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IWMIshares Tr
Recent Activity
Decreased -45.83%
18.38%
$1.149B↓ Put
5.2M shares@ $220.89 avg price
SPYSpdr S&p 500 Etf Tr
Recent Activity
Decreased -48.71%
18.36%
$1.148B↓ Put
2M shares@ $573.76 avg price
PTCTPtc Therapeutics Inc
Recent Activity
Increased 3.92%
4.3%
$268.415M
7.235M shares@ $37.11 avg price
CYTKCytokinetics Inc
Recent Activity
Increased 33.62%
3.46%
$216.299M
4.097M shares@ $52.8 avg price
SUPNSupernus Pharmaceuticals Inc
Recent Activity
Decreased -3.33%
2.55%
$158.893M
5.096M shares@ $31.18 avg price
INCYIncyte Corp
Recent Activity
Increased 24.5%
2.33%
$145.163M
2.196M shares@ $66.11 avg price
IMVTImmunovant Inc
Recent Activity
Increased 21.53%
1.89%
$117.689M
4.128M shares@ $28.51 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Increased 1.98%
1.72%
$106.996M
7.648M shares@ $13.99 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
Increased 6.16%
1.57%
$98.06M
2.207M shares@ $44.43 avg price
GRFSGrifols S A
Recent Activity
Increased 20.84%
1.36%
$84.68M
9.536M shares@ $8.88 avg price